Tumor microenvironment-responsive polymeric nanoparticles for enhanced immunotherapy

Cancer remains a major global health threat with the World Health Organization reporting 20 million new cases and 9.7 million deaths worldwide in 2022 that is projected to surge by 77% to 35% million annual cases by 2050[1][1]. In recent years immunotherapy has rapidly advanced, offering new hope